24
Participants
Start Date
October 10, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
January 31, 2024
Endocalyx Pro (Microvascular Health Solutions, US Patent Number: 9943572)
Subjects will receive Endocalyx Pro (Microvascular Health Solutions, US Patent Number: 9943572) (3,712mg) or placebo for 12 weeks.
University of Iowa, Iowa City
University of Iowa
OTHER